Canine Myxomatous Mitral Valve Disease
Changbaig Hyun, Yong-Wei Hung | 범문에듀케이션
66,500원 | 20251101 | 9791159435317
이 책은 이러한 혼란스러운 우리나라 임상 환경에서 임상 수의사들이 이첨판 폐쇄부전증에 의한 심부전의 진행 단계를 보다 객관적인 검사 지표를 통해 진단 내리고 이를 통해 보다 적절하게 심부전에 대한 약물 관리를 할 수 있게 가이드라인을 제공하고자 저술하였다.
이 책은 크게 5장으로 구성되어 있다. 1장은 심혈관계의 해부학적 구조와 기능에 대해 소개하고 있고, 2장은 심부전의 치료제와 치료전략에 대해 다루고 있으며, 3장은 이첨판 폐쇄부전증에 대한 내용을 열거하고 있다. 4장은 다양한 형태의 이첨판 폐쇄부전증 환자의 임상 증례를 소개하고 있다. 마지막 5장은 신약물과 최신 연구결과, 외과적 치료법 내용을 설명하고 있으며, 저자가 사용하고 있는 이 질환의 영상 진단 기준은 부록을 통해 소개하고 있다.
이 책이 소동물 임상 수의사들에게 개의 이첨판 질환을 진단하고 관리하는 데 도움이 되었으면 하는 소망을 가지고 저술하였다
CANINE MYXOMATOUS MITRAL VALVE DISEASE (CHRONIC MITRAL VALVE INSUFFICIENCY)
Canine myxomatous mitral valve disease is the definitive, all-in-one resource for under¬standing and managing the most prevalent acquired heart disease in dogs.
Authored by Dr. Changbaig Hyun & Yong-Wei Hung, a world-renowned authority on vet¬erinary cardiology and interventional cardiac therapy, this comprehensive textbook bridges the gap between foundational cardiovascular science and cutting-edge clinical practice.
The book provides an in-depth, evidence-based review of the pathology and progression of myxomatous mitral valve disease (MMVD), detailing current diagnostic methodologies, including advanced echocardiography and cardiac biomarkers. Crucially, it offers clear, sys¬tematic treatment guidelines for all stages of the disease, from asymptomatic to refractory heart failure.
With dedicated chapters on practical case studies and the latest interventional, surgical, and pharmaceutical therapeutics, this volume is an essential guide for veterinary practi¬tioners, specialists, residents, and advanced students seeking to master the complexities of MMVD and significantly improve long-term outcomes for their canine patients.
Over the past several decades, my career has been dedicated to advancing the field of veter¬inary cardiology, with a particular focus on the profound challenges posed by myxomatous mitral valve disease (MMVD). This degenerative disease, often a silent threat, remains the leading cause of heart failure in our small canine companions. It has been my enduring professional mission to contribute to better diagnostic clarity and more effective treatment options, including the development of new interventional and surgical therapies.
This textbook, Canine Myxomatous Mitral Valve Disease, is the culmination of my clinical experience, research findings, and years spent educating countless students and veterinari¬ans both domestically and internationally.
My primary goal in writing this book is to provide practitioners with a single, comprehen¬sive resource-a guide that systematically covers the fundamental anatomy, pharmacologic strategies, and the latest advancements in interventional and surgical management. I hope this volume not only deepens your understanding of MMVD’s complexities but also serves as an immediately practical reference to enhance the quality of care and improve the lon¬gevity of your patients.
I extend my sincere gratitude to co-author Dr. Yong-Wei Hung, my colleagues, students, and, most importantly, the dedicated owners who entrust their beloved companions to our care.
May this book serve as a valuable tool in our shared commitment to veterinary excellence.
Dr. Changbaig Hyun, DVM, PhD
